Ross’ Story
Find out more about how Cure Leukaemia's funding impacts patients in Glasgow and across Scotland
Cure Leukaemia is proud to play a vital role in supporting blood cancer patients across Glasgow. At The Beatson, we fund a dedicated clinical research nurse who ensures patients have access to pioneering treatments and potentially life-saving clinical trials.
Our support also extends to young patients and their families, with The Royal Hospital for Children also being an important part of the ATICUS Network – a groundbreaking initiative bringing together leading centres to deliver world-class care and research opportunities.
Together, these efforts help to provide hope, innovation, and improved outcomes for people facing blood cancer in our city.
Discover which clinical trials have been delivered in Glasgow, with support of funding from Cure Leukaemia
The VICTOR trial is a groundbreaking clinical trial available at TAP Centres across the UK, comparing a combination of two targeted drugs to traditional chemotherapy. This trial, specifically designed for AML patients aged 60 and over, offered a less toxic and more manageable treatment option.
A Phase 2 randomised trial for adults with Richter’s syndrome, a rare and aggressive form of lymphoma. The STELLAR trial is the first randomised trial for Richter’s syndrome in the UK, and it demonstrates the nation’s growing ability to run trials in rare diseases. The study also includes crucial translational research that will help tailor future therapies.
Focused on patients with Myelofibrosis, the Fedora trial is tackling a critical area of unmet need, gathering information about whether a combination of treatments is tolerated, and whether it provides a therapeutic benefit to patients. The FEDORA Trial has now completed recruitment, with results expected to be published soon.
This pioneering Phase 2 platform trial is evaluating Zanubrutinib therapy in adults with relapsed brain lymphoma. In the first year, 20 patients with this rare and aggressive blood cancer were recruited, with first results due to be presented at an international conference next month. Later this year, recruitment will re-commence for a further 20 patients using a world-first three-drug combination, offering long-term hope for those facing limited treatment options.
Ross’ Story
Amelie’s Story
Hughie’s Story
We’re delighted to have been selected by Sir Chris Hoy as a charity partner for the Tour de 4 2026!
This is a proud and exciting moment for Cure Leukaemia and one that will enable us to accelerate the opening of the ATICUS Network with the aim of one day finding a cure for all children with this cruel and indiscriminate disease.
Dr Nick Heaney, Consultant Haematologist in Glasgow, commented:
“As a treatment team in Glasgow caring for children and young people from across Scotland, we are delighted that the ATICUS Network has chosen to support our work and extremely grateful to Sir Chris Hoy for his support. The fundraising will help us strengthen collaboration with leading centres across the UK, ensuring every child, wherever they live, has access to the highest standard of care and the most innovative, promising new therapies.”
Get involved in some of our upcoming events in Leeds and raise vital funds to help us continue to support patients across the region